Bayer says had productive meeting with Trump over Monsanto deal

FRANKFURT, Jan 12 (Reuters) - German drugs and pesticides maker Bayer, which will need regulatory approval for its $66 billion deal to buy U.S. seeds giant Monsanto, said company chief executives had a productive meeting with U.S. president-elect Donald Trump.